GC
Grimes & Company’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.74M | Buy |
201,452
+45,143
| +29% | +$1.73M | 0.21% | 96 |
|
|
2025
Q1 | $6.06M | Buy |
156,309
+16,434
| +12% | +$637K | 0.19% | 99 |
|
|
2024
Q4 | $4.73M | Buy |
+139,875
| New | +$4.73M | 0.14% | 103 |
|
|
2016
Q4 | – | Sell |
-5,653
| Closed | -$244K | – | 207 |
|
|
2016
Q3 | $244K | Buy |
5,653
+286
| +5% | +$12.3K | 0.03% | 172 |
|
|
2016
Q2 | $232K | Buy |
5,367
+234
| +5% | +$10.1K | 0.03% | 181 |
|
|
2016
Q1 | $209K | Sell |
5,133
-1,515
| -23% | -$61.7K | 0.03% | 182 |
|
|
2015
Q4 | $268K | Buy |
6,648
+1,320
| +25% | +$53.2K | 0.04% | 163 |
|
|
2015
Q3 | $205K | Buy |
+5,328
| New | +$205K | 0.03% | 176 |
|
|
2015
Q2 | – | Sell |
-4,580
| Closed | -$212K | – | 195 |
|
|
2015
Q1 | $212K | Buy |
+4,580
| New | +$212K | 0.05% | 147 |
|
|
2014
Q3 | – | Sell |
-3,873
| Closed | -$207K | – | 170 |
|
|
2014
Q2 | $207K | Buy |
3,873
+115
| +3% | +$6.15K | 0.05% | 148 |
|
|
2014
Q1 | $201K | Buy |
+3,758
| New | +$201K | 0.06% | 138 |
|